GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JiangXi Tianxin Pharmaceutical Co Ltd (SHSE:603235) » Definitions » Capital Expenditure

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Capital Expenditure : ¥-591.37 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is JiangXi Tianxin Pharmaceutical Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

JiangXi Tianxin Pharmaceutical Co's cash flow for capital expenditures for the three months ended in Mar. 2024 was ¥-115 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-591.37 Mil.

JiangXi Tianxin Pharmaceutical Co Capital Expenditure Historical Data

The historical data trend for JiangXi Tianxin Pharmaceutical Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JiangXi Tianxin Pharmaceutical Co Capital Expenditure Chart

JiangXi Tianxin Pharmaceutical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial -237.46 -303.04 -215.50 -260.50 -535.60

JiangXi Tianxin Pharmaceutical Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -59.59 -146.47 -143.55 -185.99 -115.36

JiangXi Tianxin Pharmaceutical Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-591.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JiangXi Tianxin Pharmaceutical Co Ltd (SHSE:603235) » Definitions » Capital Expenditure
Comparable Companies
SZSE:002946 SZSE:002626 SHSE:600305 SZSE:002216 SHSE:600186 SZSE:002840 SHSE:600597 SZSE:002100 SZSE:002567 SZSE:300973 XSWX:NESN KHC XPAR:BN GIS SHSE:603288 NSE:NESTLEIND SZSE:300999 SHSE:600887 TSE:2802 LSE:ABF
Traded in Other Exchanges
N/A
Address
Le'anjiang Industrial Park, Jiangxi Province, Leping, CHN, 333300
Website
http://www.txpharm.com
JiangXi Tianxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of monomeric vitamin products.

JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Headlines

No Headlines